• Stage 1 CKD
• Stage 3 Chronic Kidney Disease
• End-Stage Renal Disease (ESRD)
• Diabetic Kidney Disease

• Sudden Kidney Failure
• Electrolyte Imbalance
• Fluid Overload
• Uraemia

• IgA Nephropathy
• Lupus Nephritis
• Post-Infectious Glomerulonephritis
• Rapidly Progressive Glomerulonephritis

• Hypertensive Nephropathy
• Renal Artery Stenosis
• Chronic High Blood Pressure Kidney Damage
• Ischaemic Nephropathy

• Minimal Change Disease
• Membranous Nephropathy
• Proteinuria
• Haematuria

• Autosomal Dominant Polycystic Kidney Disease (ADPKD)
• Alport Syndrome
• Medullary Cystic Kidney Disease
• Inherited Nephritis

• Kidney Stones
• Renal Tubular Acidosis
• Recurrent Urinary Tract Infections (UTI)
• Electrolyte Disorders

• Standard haemodialysis for chronic kidney disease management
• High-flux dialysis for enhanced toxin removal
• Online haemodiafiltration (OL-HDF) advanced dialysis therapy
• Safe vascular access care & dialysis monitoring services

• Continuous ambulatory peritoneal dialysis (CAPD) services
• Automated peritoneal dialysis (APD) treatment support
• Home-based dialysis training & patient education programme
• Comprehensive monitoring for peritoneal dialysis patients

• Continuous renal replacement therapy (CRRT) for ICU patients
• Sustained low-efficiency dialysis (SLED) procedures
• Emergency renal replacement therapy for acute kidney injury
• Advanced critical care nephrology & fluid management

• Comprehensive kidney transplant evaluation & work-up
• Pre-transplant donor & recipient assessment services
• Post-transplant kidney monitoring & immunosuppressive care
• Management of transplant-related complications & rejection

Shree Hospitals Mumbai offers the complete urine and kidney function diagnostic portfolio — urine routine and microscopy with phase-contrast, spot urine ACR, spot urine PCR, 24-hour urine protein, creatinine clearance (Cockcroft-Gault, CKD-EPI), 24-hour urine electrolytes, osmolality, urine protein electrophoresis (Bence Jones protein), urine cytology, fractional excretion of sodium (FENa), urine uric acid, oxalate, calcium, and citrate for stone risk assessment — enabling the most precise kidney function characterisation across India.

Our renal imaging service at Shree Hospitals, Mumbai provides renal ultrasound with size and echogenicity assessment, renal resistive index (Doppler), renal artery duplex Doppler, dimercaptosuccinic acid (DMSA) scan for cortical scarring and differential renal function, diuretic renogram (MAG3) for obstruction assessment, CT KUB for urolithiasis, MRI renal (BOLD for oxygenation, diffusion), CT renal angiography for renovascular assessment, and renal transplant Doppler — the most comprehensive renal imaging service available at an nephrology centre in Mumbai, India.

Shree Hospitals provides percutaneous renal biopsy under real-time ultrasound guidance with automated 16G biopsy gun, tissue triage for light microscopy (H&E, PAS, Masson trichrome, Jones silver), direct immunofluorescence (DIF) for IgG, IgA, IgM, C3, C1q, fibrinogen, and kappa/lambda light chains, electron microscopy (EM) for ultrastructural podocyte and GBM assessment, and Congo red for amyloid — providing the gold-standard kidney biopsy diagnostic service in Mumbai and India.

Our nephro-immunology laboratory at Shree Hospitals Mumbai provides the complete glomerular disease serology panel — ANA, anti-dsDNA, ANCA (c-ANCA/PR3, p-ANCA/MPO), anti-GBM antibody, anti-PLA2R (membranous nephropathy), anti-THSD7A, cryoglobulins, SPEP and UPEP, serum free light chains, cryoglobulin typing, hepatitis B and C serology, HIV screen, complement (C3, C4, CH50, AP50, C3 nephritic factor), and anti-C1q — enabling precise immunological diagnosis of kidney disease for patients across India.

Shree Hospitals provides comprehensive dialysis quality monitoring — monthly Kt/V and URR for haemodialysis adequacy, peritoneal equilibration test (PET), 24-hour dialysate protein loss, residual renal function measurement, nPCR (normalised protein catabolic rate), pre-dialysis phosphate and PTH, ferritin and transferrin saturation, beta-2 microglobulin (middle molecule marker for HDF adequacy), AV fistula and graft surveillance ultrasound, and dialysis water quality analysis — ensuring every patient on RRT at Shree Hospitals Mumbai receives safe, effective, guideline-compliant therapy across India.

Shree Hospitals provides genetic nephropathy testing — PKD1/PKD2 sequencing for ADPKD, COL4A3/4/5 for Alport syndrome, GLA for Fabry disease (with enzyme assay), NPHS1/NPHS2 for congenital nephrotic syndrome, WT1 for Denys-Drash syndrome, and whole-exome sequencing panels for unexplained childhood CKD — alongside complete metabolic stone evaluation (24-hour urine calcium, oxalate, citrate, phosphate, uric acid, cystine, pH, volume) and renal tubular disorder workup for patients seeking nephrology treatment in Mumbai, India.